Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation THKKF


Primary Symbol: V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by Possibleidiot01on Feb 16, 2024 8:59am
76 Views
Post# 35883791

RE:RE:RE:RE:Investor relations rating

RE:RE:RE:RE:Investor relations rating"I am quite certain that Beedie expects to make out like bandits on this deal"

That's the one sure thing here.

Maybe somebody should try to figure out if 32 cents actually represents a premium to the the existing options ; the latest of which were done at 0.2688. Previous ones done at 35 cents and above. My brain isn't up to this at this time.

My suspicision is that the touted 100% premium is a nothing burger when taken in conjunction with the existing loan options.

As for the 48.21% of shareholders who are rolling their shares over , this is a trend creating two classes of shareholders that I detest. Magnet Forensics was an another example.

30 day shop period and a small break fee , $1.2 million.

dt-core , I've always wondered since Agjunction , are you Canadian like me  or American?
<< Previous
Bullboard Posts
Next >>